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Functional non-epileptic attacks (FNEA) are seizure-like events occurring in the
absence of epilepsy. Having had many diﬀerent names over the years including
dissociative convulsions and pseudo-seizures, they now fall in the borderland
between neurology and psychiatry, often not accepted by either specialty. However,
there is evidence that there is a high rate of psychiatric comorbidity in these patients
and therefore it is likely that psychiatrists will come across patients with FNEA and
they should know the broad principles of assessment and management.
We have provided a clinically based overview of the evidence regarding
epidemiology, risk factors, clinical features, diﬀerentiation from epilepsy, prognosis,
assessment and treatment.
By the end of this article, readers should be able to understand the diﬀerence
between epileptic seizures and FNEA, know how to manage acute FNEA, and
understand the principles of neuropsychiatric assessment and management of these
patients, based on knowledge of the evidence base.
Consent statement Informed consent was obtained from the patient for publication
of Box 1.
Declaration of interest None.
Keywords Dissociative disorders; functional non-epileptic attacks; psychogenic
non-epileptic seizures; dissociative convulsions; neuropsychiatry.
Clinical scenario
You are a core trainee in a community mental health team,
working in an out-patient clinic. You come out to call your
next patient when you see a 40-year-old woman lying on her
back on the ground with her eyes closed in the waiting room,
with people crowding around her. The receptionist informs
you that she arrived a few minutes late in a distressed state
and was asked to take a seat. Within a minute she was seen
slumping inher chair and then slidingdown to the ground, jerk-
ing all four limbs while crying. When you approach her and try
to talk, she responds to your questions and soon opens her eyes
and her shaking stops, but she then slips back into jerking all
four limbs again. You see on her wrist that she has a medical
alertbracelet,which reads ‘medical alert: non-epilepticattacks’.
• What would be your immediate management of the
situation?
• What are the principles of assessment and management
in functional non-epileptic attacks (FNEA)?
• What are the diﬀerences between epileptic seizures and
non-epileptic attacks?
Evidence base in FNEA
FNEA are when people present with what looks like epileptic
seizures but they do not have epilepsy or associated
electroencephalogram (EEG) changes or a physiological
condition that may mimic seizures such as syncope. This
condition is also known as psychogenic non-epileptic sei-
zures (PNES), non-epileptic attack disorder (NEAD), psy-
chogenic seizures, hysterical seizures and so on. In ICD-10
(1992) they are classiﬁed as ‘dissociative convulsions’, in
ICD-11 (2018) as ‘dissociative neurological symptom dis-
order’ and in DSM-5 (2013) as ‘functional neurological
symptom disorder – with attacks or seizures’. The change
in terminology over the years reﬂects the changes in theor-
etical underpinning and clinical understanding. FNEA have
been described in multiple cultures without a speciﬁc
diagnostic label for 4000 years, the term hysteria was then
used for the next 2500 years,1 followed by conversion,
dissociation and now FNEA, which is theoretically neutral
from a psychological standpoint and considered to be
acceptable to patients.2
FNEA are commonly seen in neurological and accident
and emergency (A&E) settings. Up to one in ﬁve patients
in epilepsy clinics present with FNEA and 20–40% of
patients in epilepsy-monitoring in-patient units have
FNEA.3 These patients or their carers will often initially
call an ambulance and present to A&E departments.
Indeed, nearly a quarter of FNEA patients report an episode
of FNEA status,4 which may in some cases even lead to
intubation in the intensive treatment unit. The estimated
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prevalence of FNEA is 2–30/100 000 in the general popula-
tion5 and population incidence has been estimated to be 1.4–
4.9/100 000/year.3 By contrast, the median estimated popu-
lation incidence of multiple sclerosis is 4.2/100 000/year
and that of epilepsy is 48/100 000/year.6 FNEA most com-
monly present in young adulthood and in women, but can
occur in children, older adults and men.3
The aetiology of FNEA, as with functional neurological
disorders in general, is thought to be multifactorial. Risk fac-
tors include female gender, childhood abuse and neglect, avoi-
dant coping styles, previous functional disorders and
somatisation, and recent stressful event which may itself be
‘organic’ – such as a head injury or syncope.7 In addition,
FNEA are associated with neuropsychological deﬁcits and
alexithymia.7 Often overlooked is a family history of func-
tional disorders, although there have been no positive genetic
ﬁndings to date.8 There is an association with personality dis-
order, especially cluster B and cluster C personality disor-
ders,9 and a number of patients have other psychological
comorbidities such as aﬀective disorders and anxiety disor-
ders,10 which may act as predisposing, precipitating or per-
petuating factors. Symptoms of panic and dissociation are
common leading up to an attack, and patients may even
‘bring on’ an attack to rid themselves of these symptoms.11
Distinguishing epileptic from non-epileptic attacks can
be diﬃcult, and it is important to remember that there are
no clinical signs that never occur in epilepsy, and the only
certain diagnostic feature of epileptic versus non-epileptic
attacks is video EEG (vEEG) conﬁrming epileptic or
non-epileptic seizures.10 If this shows the absence of epilep-
tiform activity in the presence of the patient’s typical attacks,
it conﬁrms the diagnosis of FNEA. vEEG is of course only
diagnostic if the attack occurs during monitoring and can
be falsely negative on scalp EEG if there is an ictal focus
deep in the frontal lobe. However, vEEG is expensive and
is carried out in only some cases. Diagnosis is largely clinical,
based on good history and clinical observation of an attack,
ideally supplemented by clinician-viewed video of the attack.
Table 1 helps distinguish clinical features of epileptic versus
non-epileptic attacks, but should not be used in isolation to
make a diagnosis either way.
Confusingly, some patients with epileptic seizures may
also have non-epileptic attacks. What is important in this
case is the semiology (clinical features of the seizure) and
whether it is diﬀerent from the patient’s normal epileptic sei-
zures. Epileptic seizures tend to be short, stereotyped and
highly consistent, although of course they can take diﬀerent
forms in the same patient, e.g. simple and complex.
However, in the case of the emergence of a new seizure type
in a patient with stable epilepsy, FNEA should be considered.
In terms of prognosis and outcomes, data suggest that
4 years after diagnosis around a third of patients will be
attack free.14 However, being attack free alone does not
result in greatly improved levels of psychopathology or
recovery of social function, as nearly half of patients who
are attack free are still in receipt of state beneﬁts.14 These
data suggest that social interventions aimed at recovery of
social function, e.g. going back to work, may be eﬃcacious
in improving quality of life more than aiming for patients
to be attack free; however there are no studies examining
social interventions alone and this is a gap in the literature.
Furthermore, there is a general lack of long-term follow-up
studies of patients with FNEA. Features associated with a
favourable prognosis include lack of past psychiatric history,
identiﬁable recent stressor, short duration of FNEA, higher
socioeconomic class, normal IQ, lower age, less vigorous sei-
zures, absence of comorbid epilepsy and no ongoing use of
anticonvulsant medication.7,12
Multiple treatments have been trialled including
cognitive–behavioural therapy (CBT) (both individual and
Table 1 Distinguishing clinical features in FNEA and epilepsy.
Feature FNEA Epilepsy
Onset in certain situations Sometimes Rarely
Gradual onset Commonly Rarely
Over 2 minutes duration Commonly Rarely
Asynchronous limb movements Commonly Rarely
Purposeful movements Sometimes Very rarely
Thrashing, violent movements Commonly Rarely
Side-to-side head movements Commonly Rarely
Tongue biting of tip Sometimes Rarely
Tongue biting of side Rarely Commonly
Eyes closed Very commonly Rarely
Resistance to eye opening Commonly Very rarely
Pupillary light reﬂexes Commonly retained Commonly absent
Ictal crying or vocalisations Sometimes Very rarely
Incontinence Sometimes Commonly
Post-ictal rapid reorientation Commonly Uncommonly
Absence of cyanosis Commonly Rarely
Adapted from Reuber & Elger12 and Mellers.13 FNEA, functional non-epileptic attacks.
183
PRAXIS
Sheldon & Agrawal Functional non-epileptic attacks
group based), paradoxical treatment, psychodynamic therapy,
group therapy, family therapy, case management, eye move-
ment desensitisation and reprocessing, acceptance and com-
mitment therapy and multimodular approaches.7,12,15–18
However, the evidence base is hampered by lack of control
groups, small numbers of patients in trials and also the highly
variable population and presentation of FNEA.Wewould sug-
gest that the individualised treatment approach as described
in 2014 by Agrawal et al18 helps address this problem of the
high variability in FNEA patients.
The problem of small numbers in treatment trials is also
being addressed: The largest randomised controlled trial
(RCT) to date is in CBT. Goldstein et al19 conducted an
RCT of CBT versus standard medical care (SMC), with 33
patients in both arms, and seizure frequency reduced signiﬁ-
cantly in the CBT arm. However, the statistical power
reduced signiﬁcantly (P = 0.086) due to patients being lost
to follow-up. This CBT trial was extended and repeated
and is currently evaluating data as the ‘COgnitive behav-
ioural therapy versus standardised medical care for adults
with Dissociative non-Epileptic Seizures’ (CODES) trial.20
It aimed to allocate around 150 patients to each arm –
SMC and SMC with CBT – and is due to report.
Only one double-blind placebo RCT of treatment has
been published in FNEA, and this was of sertraline versus pla-
cebo.21 A total of 33 patients were assessed and a non-
signiﬁcant reduction in seizure frequency was found in the
sertraline versus placebo group. This was a feasibility study
for a larger RCT which, to date, has not been undertaken.
Assessment of FNEA
There are some key elements to the assessment of FNEA
that should never be forgotten.
(1) A clear history from both patient and an informant,
ideally supplemented by video of the attack itself, is invalu-
able. Patients with non-epileptic attacks tend to talk about
attacks in a diﬀerent way to those with epilepsy (for example,
talking about seizures by total negation and without context,
i.e. ‘I feel nothing’, ‘I don’t know anything has happened’),
whereas those with epilepsy try to give detailed explanations
of what they did experience before or after.22 It is important
to get a clear understanding of how the family react when a
non-epileptic attack occurs as, in some cases, they may inad-
vertently be reinforcing or maintaining the attacks.
(2) A good history is essential, especially for any recent
stressful events. Some patients’ attacks are clearly tempor-
ally related to a stressful event, although this is no longer
required for diagnosis.
(3) A full psychiatric history is required, assessing both past
and current mental illness. Both patients with epilepsy, and
with FNEA are more likely than the general population to
have higher rates of depression and anxiety.10 Treatment of
any comorbidities is an important part of treatment for FNEA
as – although the data are limited by small numbers – comorbid
prevalence rates of 63% with aﬀective disorders, 46% with per-
sonality disorders, 32.5% with somatoform disorders, and 19%
with both anxiety disorders and post-traumatic stress disorder
(PTSD) have been reported.23
(4) A thorough general medical history must be taken.
Patients with non-epileptic attacks have been found to be
more likely than patients with epilepsy to have functional
or medically unexplained symptoms in diﬀerent organ sys-
tems, such as ﬁbromyalgia, chronic pain and irritable bowel
syndrome.24 The most common symptom combination dis-
tinguishing FNEA from epileptic seizures in one tertiary cen-
tre study was chronic pain, migraines and asthma in FNEA
compared with diabetes and non-metastatic neoplasm in
epilepsy.25
(5) Determine the personal and social history of the
patient. Patients with non-epileptic attacks are much more
likely to report a history of abuse or neglect in childhood,
and this should be sensitively asked about along with usual
information such as birth trauma, developmental mile-
stones, head injuries and details of schooling and
Box 1. Patient experience of functional non-epileptic attacks
My dissociative seizures (NEAD) were precipitated by an episode of moderate depression and its treatment with Sertraline on transition to
university. I also was experiencing panic disorder, GAD and depersonalisation–derealisation disorder.
Everyone was very panicked by my first seizures. I visited several A&E departments, had numerous ambulance visits and was bounced between
psychiatric liaison, the A&E staff and the CMHT, even having an overnight stay in AMU. No one could give me a concrete diagnosis, or know
where to refer me. I was dosed up on benzodiazepines, which did not stop the seizures, and just made the experience harder to cope with. I
experienced PTSD following the traumatic nature of these interventions; and they were completely needless.
Psychiatrists at CMHT seemed very worried, even more so than I was, and this compounded the stress that was prolonging my condition. They
were, however, helpful in sourcing CBT to treat my anxiety and depression.
Six months after my first seizure, I was officially diagnosed with dissociative seizures. The reassurance of a diagnosis itself, along with further
research into the condition, was enough alone to cause a noticeable decrease in the severity of my seizures.
I then saw Dr Sheldon & Dr Agrawal at St George’s. Dr Agrawal drew a diagram explaining how stress can build to cause my seizures, and I used a
CBT diary to identify triggers over twomonths. I surprised myself with the diversity and number of my triggers on reviewing my diary, which I now
manage.
A greater understanding of my condition gained through psychoeducation, and the use of grounding, distancing and distracting techniques, have
all been instrumental in my recovery. I am now discharged, and almost seizure-free. I wonder howmuch better my experience could have been if
doctors had known how to treat my acute presentation?
A&E, accident and emergency; AMU, acute medical unit; CBT, cognitive–behavioural therapy; CMHT, community mental health team; GAD,
generalised anxiety disorder; NEAD, non-epileptic attack disorder; PTSD, post-traumatic stress disorder.
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relationships. Importantly however, some will not have this
history of abuse or neglect. In some cases this may need to
be asked about after developing rapport with the patient.
They should also be asked whether they are still driving.
(6) The premorbid personality should be ascertained.
Patients with non-epileptic attacks are more likely to have
a personality disorder than the general population, espe-
cially cluster B and cluster C personality disorders, although
there are methodological problems with much research in
this area.9,23
(7) The patient’s illness beliefs, concerns, wishes and
expectations should be ascertained. Research has shown
that patients who are conﬁdent in the diagnosis of FNEA
have a better outcome.26 Lasting doubts about epilepsy
should be dispelled and it must be emphasised that this con-
dition is treatable and many patients fully recover.
(8) Finally, a biopsychosocial formulation encompassing
the above factors should be composed, using predisposing,
perpetuating, precipitating and protective format. This will
guide management.
Management
The management for all patients will naturally be diﬀerent
due to the diﬀerent nature of their attacks and their individ-
ual triggers, but there are important overarching principles.
These include making the diagnosis clearly and early (and
ideally soon coming oﬀ anticonvulsants); biopsychosocial
formulation including the role others play in reaction to
attacks; psychoeducation about non-epileptic seizures; the
management of comorbidities; the development of personal
insight and understanding triggers to attacks (which can be
achieved by things such as attack diaries); oﬀering trauma-
focused therapy if appropriate; and the personal testing
and utilisation of diﬀerent techniques such as grounding,
relaxation and mindfulness. The use of benzodiazepines
and anticonvulsants can be harmful both in the short and
longer term. An overview of one such pragmatic, individua-
lised treatment pathway is provided in Agrawal et al.18
The diagnosis should in most cases be made by a
neurologist. However, many patients will beneﬁt from
neuropsychiatry-led sensitive and detailed exploration of
illness beliefs, further explanation of the diagnosis and
psychoeducation about triggers and management strategies.
In some cases, patients will have been on anticonvulsants
and will have lived with negative side-eﬀects for years, not
to mention the stigma of epilepsy and practical handicaps
from the condition, such as being unable to drive. Some
patients may only require a clear, sensitive diagnosis for
the FNEA to stop; however, these patients are thought to
be in the minority. In any case, the way a diagnosis is
made is important (Box 1).
Four models about conveying a diagnosis have been
published.13,27–29 However, what is common between models
are the principles of reassurance; discontinuation of anticon-
vulsants; providing a type of model for how FNEA come
about – including the relationship with emotions; and that
although symptoms are not consciously controlled, patients
can learn to identify triggers for seizures and learn to
intervene.
People with FNEA will ideally be seen by a psychiatrist
with experience of the assessment of FNEA and epilepsy, i.e.
a neuropsychiatrist. The multidisciplinary team is often
helpful, for example in discussing diﬃcult formulations, and
the team can oﬀer individual therapy tailored towards the
FNEA or underlying factors as appropriate. Enough time
should be set aside in clinic to explore symptoms and history
as well as management. The clinic letter can itself be a useful
tool to explore illness beliefs at the next consultation.
Whether or not patients should remain on the neuro-
logical caseload is an interesting topic and how helpful this
is has not been explored prospectively. Given some of the
similarities in interpersonal interactions with borderline
personality disorder and patients with FNEA, some believe
that consistency is key and patients should be kept in
follow-up and that discharge should be slow and gradual.9
Indeed, patients with FNEA often struggle to ﬁt in within
both neurology and psychiatry services and they bounce
between teams with clinicians reluctant to take responsibil-
ity, similar to those with personality disorders in psychiatric
services.
In an acute situation such as the above, the importance
is in diﬀerentiating from an epileptic seizure. First, getting
people to stand aside and leave the area is important to be
able to assess the patient and manage the scenario. If your
assessment is that this is a non-epileptic seizure, which
from the description is likely, then some techniques can be
used to arrest the seizure. For example, if a small mirror
(or the front-facing camera on a smartphone) is brought to
the patient’s face, observe if the pupils converge on it
(this is highly unlikely in an epileptic seizure). This mirror
technique can in some cases stop the FNEA.13 However, if
this is unsuccessful, it does not mean that this is not a
functional seizure. If the patient’s eyes are closed, it can
be helpful to open their eyes to see if they resist eye opening,
which would be very unusual in an epileptic seizure. If the
patient can be spoken to and they respond emotionally to
your voice (which, again, is common in FNEA), then you
can talk to them and calm them. You could try asking
them to tell you the day of the week, and to open their
eyes and look at something in the room and describe it in
detail. An example of such a grounding technique might
be: ‘tell me three things you can see, two things you can
hear, one thing you can smell’. If the situation continues
despite your best eﬀorts, then be reassured the FNEA will
stop eventually. It would be helpful to still see the patient
despite the attack in the waiting room, if time allows.
What is key is that the ambulance should not be called –
unless the patient has seriously injured themselves – as a
result of the FNEA and no acute pharmacological treatment
is indicated.
Such acute treatment may not only reinforce a need for
benzodiazepines or anticonvulsants, but has the potential to
increase levels of dissociation by reducing alertness. Indeed
it has been postulated that the variation in FNEA symptoms
is due to the eﬀect of anticonvulsants30 and that other drugs
inducing altered awareness states, such as anaesthetic
agents, can induce FNEA.31
Patients may ask about driving. Current Driver and
Vehicle Licensing Agency (DVLA) guidance in the UK dictates
that people with FNEA should cease driving and inform the
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DVLA of their condition. To resume driving, people with
FNEA should have episodes that are ‘suﬃciently controlled’
for 3 months as long as there are ‘no mental health issues’.
If there are ‘high-risk features’ then 6 months of control and
a ‘specialist opinion’ is required before resumption of driving.
This is the case for both group-1 and group-2 licences.32
Conclusion
We have discussed the acute and chronic management of a
patient with FNEA, highlighting the importance of indivi-
dualised assessment and management based on biopsycho-
social formulation. We would recommend that all patients
with FNEA are referred to neuropsychiatric services, but
also appreciate that due to service provision and funding
gaps this is not always possible, and furthermore many
patients have signiﬁcant psychiatric comorbidity requiring
the skills and resources of general psychiatry. Patients
with FNEA can often seem as if they do not fall neatly
within the responsibility of neurology or psychiatry; how-
ever a joint approach is likely to be the most productive
given the degree of comorbidity. Their often-arduous jour-
ney towards diagnosis and treatment demonstrates why
neurologists and psychiatrists should work, and train, in
collaboration.
The extensive gaps in the literature that have been men-
tioned include the paucity of comparative studies between
other episodic psychiatric syndromes such as panic attacks
and FNEA (with these studies tending to compare FNEA
patients with epileptic seizure patients), the lack of
large-scale neuroimaging studies and genetic studies. The
diﬃculty of establishing what abnormalities in studies are
related to childhood trauma, comorbid psychiatric illness
or the eﬀect of chronic functional symptoms makes such
studies diﬃcult to perform. Studies assessing interventions
focusing on purely social function are missing, as are large
epidemiological studies, large personality disorder studies
and studies examining the eﬀect of being on or oﬀ a neuro-
logical caseload. Double-blind RCTs are extremely few in
number, although this is not surprising as most studies are
of psychological interventions which cannot provide a true
placebo.
The earlier the diagnosis is made and biopsychosocial
assessment and management put in place, the better the
outcome, including a full resolution of symptoms. A neuro-
psychiatrist is ideally placed to do this, but a general psych-
iatrist, if following the basic principles discussed, can
achieve good outcomes with these patients.
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